LeonaBio (LONA) Total Current Liabilities (2019 - 2026)

LeonaBio (LONA) has 8 years of Total Current Liabilities data on file, last reported at $6.7 million in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $6.7 million, up 21.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.7 million (up 21.38% YoY), and the FY2025 annual result was $47.5 million, up 261.65% from the prior year.
• Total Current Liabilities fell to $6.7 million in Q1 2026 per LONA's latest filing, from $47.5 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $47.5 million in Q4 2025 and troughed at $2.8 million in Q3 2025.
• A 5-year average of $18.2 million and a median of $20.2 million in 2023 frame the typical range for Total Current Liabilities.
• On a YoY basis, Total Current Liabilities climbed as much as 261.65% in 2025 and fell as far as 89.96% in 2025.
• A 5-year view of Total Current Liabilities shows it stood at $21.4 million in 2022, then soared by 34.57% to $28.8 million in 2023, then plunged by 54.46% to $13.1 million in 2024, then soared by 261.65% to $47.5 million in 2025, then slumped by 85.97% to $6.7 million in 2026.
• Business Quant data shows LONA's Total Current Liabilities at $6.7 million in Q1 2026, $47.5 million in Q4 2025, and $2.8 million in Q3 2025.